vVARDIS prices NYSE IPO at $18 per share
Swiss dental med-tech firm vVARDIS priced its IPO at $18 a share, offering 9,722,223 Class A shares, with NYSE trading expected from November 13.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Swiss company vVARDIS Holding AG, which operates in dental med-tech, has set the price of its initial public offering at $18 per share. According to TradingView, the deal covers 9,722,223 Class A ordinary shares. Trading under the ticker VVVV on the New York Stock Exchange is expected to begin on November 13, 2026, and the closing is planned for about November 16.
The underwriters have a 30-day option to buy up to 1,458,333 additional shares at the offering price. Goldman Sachs and J.P. Morgan are joint bookrunning managers. The Form F-1 registration statement was declared effective on November 12, 2026.
why it matters
A single IPO from a niche medical-technology company typically does not move the broader market, but specialists in new issues and medtech will watch the listing. The over-allotment option gives the underwriters room to support the share price in the first weeks of trading.
tags
instruments
sources
- vVARDIS Announces Pricing of Initial Public Offering — TradingView, 13 November 2026 at 05:02 UTC
- Vvardis Announces Pricing Of Initial Public Offering — Reuters, 13 November 2026 at 05:03 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗